Spanish Study of MDMA-Assisted Therapy for Posttraumatic Stress Disorder (Concluded) Started in 2000, this study was the world’s first clinical trial to evaluate the safety and effectiveness of MDMA-assisted …
MAPS colleague Jose Carlos Bouso, Ph.D. Candidate, previous principal investigator of an MDMA/PTSD study in Spain, did not receive a 200,000 Euro government grant he had applied for last year. Jose had …
Unfortunately, a several hundred thousand euro grant that MAPS colleague and Spanish Researcher Jose Carlos Bouso, Ph.D. Candidate applied for to conduct an MDMA/PTSD study in Spain was rejected. MAPS …
On March 15, 2004, the lead investigator for MAPS’ concluded Spanish study of MDMA-assisted psychotherapy for PTSD, Jose Carlos Bouso, PhD, submitted this political analysis: Now that the progressive …
On March 12. 2004, Jose Carlos Bouso, PhD, participated in a televissd debate about drug policy. Here is his report: Neither the Director of the Spanish Antidrug Agency nor the Director of the Madrid Antidrug …
On March 4, 2004, the lead investigator for our Spanish study of MDMA-assisted psychotherapy for PTSD, Jose Carlos Bouso, PhD, was invited to participate in a Spanish TV program on March 12, 2004, along …
One of most important national Spanish newspapers (El Mundo) published an article regarding the final approval of the US MDMA/PTSD study in its Science section. The article is quite favorable and also …
On September 13, 2003, the Spanish medical journal Medicina Clínica published Jose Carlos Bouso’s letter to the editor (PDF, page 3) entitled “MDMA (‘ecstasy’) psychotherapy …
On May 28, 2003, José Carlos Bouso, PhD, learned that a Letter to the Editor that he wrote to the Spanish Medical Journal Medicina Clínica (Clinical Medicine), was accepted for publication. The …
On April 28, 2003, a lengthy article in the prominent Spanish magazine Interviu reported on the controversy surrounding the Spanish MDMA/PTSD study and brought to light the fact that the Madrid Anti-Drug …
The fourth patient in the Spain MDMA/PTSD dose-response study was treated on November 28, 2001. We have now completed the 50 mgs dose group (3 patients received 50 mgs and 1 received a placebo). The next …
The first patient was treated in the MAPS-supported MDMA/PTSD study being conducted in Madrid, Spain, under the director of José Carlos Bouso, Ph.D. candidate. José Carlos and Marcela Ot’alora …